MANS-NRIZ Trial for COVID-19 Treatment : Extension Study
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This search will focus on patients with COVID 19 infection this study is a prospective cohort
study based on the analysis of response in comparative panel between two arm Nitazoxanide,
Ribavirin and Ivermectin plus Zinc arm and other arm without any intervention as regards the
safety and efficacy and cost effective result. Two years duration of the project would be
enough to cover the stages of the work as shown below in the time plan. Initial stage of
collecting materials and patients' clinical data, each patient will undergoes strict follow
up period to reveal the clinical, laboratory and radiological response. The procedures are to
be approved by the institutional ethical committee.